Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2003
07/31/2003CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/30/2003EP1330443A1 Substituted phenyluracils
07/30/2003EP1330442A1 Phthalazinone derivatives
07/30/2003EP1330430A2 Integrin receptor inhibitors
07/30/2003EP1233960B1 Polymorphic salt of an anti-migraine drug
07/30/2003EP1027348B1 2-(2'-hydroxyphenyl)benzotriazoles used as u.v. stabilisers
07/30/2003EP0835252B1 Triazole antifungal agents
07/30/2003CN1433414A Benzazole derivatives and their use as JNK modulators
07/30/2003CN1433406A BenzoÒÇöaÒÇòphenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and Ôàí"
07/30/2003CN1433405A Quinazoline compounds
07/30/2003CN1433402A Cycloamine CCR5 receptor antagonists
07/30/2003CN1433312A Barbituric acid analogs as therapeutic agents
07/30/2003CN1433297A Topical compositions comprising protected functional thiols
07/30/2003CN1116281C Acryloyl substituted distamycin derivative, process for preparing them,and use as antitumor and antiviral agents
07/29/2003US6600043 Carboxylic acid derivatives, their preparation and use
07/29/2003US6600037 4,5-disubstituted-2-aminopyrimidines
07/29/2003US6599926 Anticoagulant agents for treatment and prevention of thromboembolic disorders
07/29/2003US6599910 Substituted triazole compounds
07/29/2003US6599908 Fused polycyclic 2-aminopyrimidine derivatives
07/29/2003US6599902 For treating or preventing a protein kinase related disorder
07/29/2003US6599898 Use of certain substituted caprolactam carbonates and ethers in treating tumors
07/29/2003US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants
07/24/2003WO2003060475A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003WO2003059910A1 Intermediates for preparing glycogen phosphorylase inhibitors
07/24/2003WO2003059905A1 Pyrrolidone carboxamides
07/24/2003WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
07/24/2003WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003WO2003059892A1 Substituted alkyl uracils and the use thereof
07/24/2003WO2003059887A1 Substituted pyrazolines for use as pesticides
07/24/2003WO2003059881A2 Dna minor groove binding compounds
07/24/2003WO2003059341A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003US20030139609 Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles
07/24/2003US20030139500 Compositions stabilized by dioxopiperazinyl derivatives
07/24/2003US20030139463 Anticancer agents; antiarthritic agents
07/24/2003US20030139452 Pyrazole-derived kinase inhibitors and uses thereof
07/24/2003US20030139450 Respiratory syncytial virus
07/24/2003US20030139435 N-heterocyclic inhibitors of TNF-alpha expression
07/24/2003US20030139425 Piperazine derivatives and their use as anti-inflammatory agents
07/24/2003US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
07/24/2003US20030139416 Anticancer agents; kidney disease
07/24/2003US20030139409 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
07/24/2003US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators
07/24/2003US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/24/2003US20030139403 Antiinflammatory agents; antidiabetic agents; skin disorders; rheumatic diseases
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139400 Controlling cell differentiation; antiinflammatory agents
07/24/2003US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
07/24/2003US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
07/24/2003US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
07/24/2003US20030139388 Antiinflammatory agents; osteoporosis
07/24/2003US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders
07/24/2003US20030139377 Bactericides; enzyme inhibitors
07/24/2003US20030139373 Method for cancer therapy
07/24/2003US20030139348 Animal growth regulators
07/24/2003US20030138662 A dibenzoquinoxaline compounds electron transporting materials; flat-panel display, electroluminescence
07/24/2003CA2651604A1 Method for preparation of substantially amorphous telmisartan
07/24/2003CA2473362A1 Substituted alkyl uracils and the use thereof
07/24/2003CA2473236A1 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003CA2472469A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
07/24/2003CA2472205A1 Intermediates for preparing glycogen phosphorylase inhibitors
07/24/2003CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003CA2471620A1 Pyrrolidone carboxamides
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP1329218A1 Preventives/remedies for portal hypertension
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
07/23/2003EP1056742B1 Anti-viral pyrimidine derivatives
07/23/2003EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2003EP0763529B1 Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same
07/23/2003EP0628033B1 Benzodiazepin derivatives useful as cck-receptor antagonists
07/23/2003CN1432013A Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
07/23/2003CN1432004A Alkynyl phenyl heteroaromatic glucokinase activators
07/23/2003CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis
07/23/2003CN1115339C Novel sulfonylaminopyrimidines
07/23/2003CN1115337C Pyrimidinone derivatives
07/23/2003CN1115336C 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator
07/22/2003US6596876 Prostaglandin I2 inhibitors
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596845 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents
07/22/2003US6596754 Preventives/remedies for multiple organ failure
07/22/2003US6596749 Neuropeptide y receptor ligand
07/22/2003US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I):
07/22/2003US6596732 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
07/22/2003US6596723 Fungal efflux pump inhibitors
07/22/2003US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides
07/22/2003US6596461 Piperazinone derivatives
07/22/2003US6596364 Squarylium compounds and optical recording medium containing the same
07/22/2003CA2239603C Quinolines and quinazolines useful in therapy
07/17/2003WO2003058667A1 Organic light-emitting devices
07/17/2003WO2003057690A1 Indolinone derivatives useful as protein kinase inhibitors
07/17/2003WO2003057689A1 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
07/17/2003WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057673A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057669A1 Androgen receptor antagonists
07/17/2003WO2003057666A2 Inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
07/17/2003WO2003057214A1 Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 626